nodes	percent_of_prediction	percent_of_DWPC	metapath
Nandrolone phenpropionate—Testosterone Propionate—CYP17A1—melanoma	0.0163	0.375	CrCbGaD
Nandrolone phenpropionate—Progesterone—CYP17A1—melanoma	0.00749	0.172	CrCbGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—TP73—melanoma	0.00674	0.00705	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—XRCC3—melanoma	0.00668	0.00698	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP1B1—melanoma	0.00654	0.00684	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Oxidation by Cytochrome P450—CYP1B1—melanoma	0.00646	0.00675	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metapathway biotransformation—AKR1B10—melanoma	0.00638	0.00667	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—HDAC2—melanoma	0.00637	0.00666	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear SMAD2/3 signaling—FOXO4—melanoma	0.00631	0.0066	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear SMAD2/3 signaling—HDAC2—melanoma	0.00631	0.0066	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Phase 1 - Functionalization of compounds—CYP17A1—melanoma	0.0063	0.00659	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nuclear Receptors—PPARG—melanoma	0.00628	0.00656	CbGpPWpGaD
Nandrolone phenpropionate—AR—Notch-mediated HES/HEY network—HIF1A—melanoma	0.00623	0.00651	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear SMAD2/3 signaling—IFNB1—melanoma	0.00619	0.00647	CbGpPWpGaD
Nandrolone phenpropionate—AR—Notch-mediated HES/HEY network—KDR—melanoma	0.00596	0.00623	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—NODAL—melanoma	0.00573	0.00599	CbGpPWpGaD
Nandrolone phenpropionate—AR—Notch-mediated HES/HEY network—NOTCH1—melanoma	0.00561	0.00587	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Phase 1 - Functionalization of compounds—CYP1B1—melanoma	0.0053	0.00554	CbGpPWpGaD
Nandrolone phenpropionate—Progesterone—CYP1B1—melanoma	0.00519	0.119	CrCbGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—CASP10—melanoma	0.00511	0.00534	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—MAP3K5—melanoma	0.00511	0.00534	CbGpPWpGaD
Nandrolone phenpropionate—AR—Notch-mediated HES/HEY network—RB1—melanoma	0.00507	0.0053	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear SMAD2/3 signaling—CDKN2B—melanoma	0.00504	0.00527	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—MSH2—melanoma	0.005	0.00523	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nuclear Receptor transcription pathway—PPARG—melanoma	0.00496	0.00519	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear SMAD2/3 signaling—VDR—melanoma	0.00491	0.00514	CbGpPWpGaD
Nandrolone phenpropionate—Testosterone—CYP1B1—melanoma	0.00491	0.113	CrCbGaD
Nandrolone phenpropionate—AR—Regulation of nuclear SMAD2/3 signaling—IL10—melanoma	0.00478	0.005	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—DCC—melanoma	0.00472	0.00493	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Ovarian Infertility Genes—CDKN1B—melanoma	0.00462	0.00483	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—APAF1—melanoma	0.00458	0.00479	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—WT1—melanoma	0.00434	0.00454	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nongenotropic Androgen signaling—MAPK3—melanoma	0.00433	0.00453	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—MSH2—melanoma	0.0043	0.0045	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TERT—melanoma	0.00426	0.00445	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—ACER3—melanoma	0.00422	0.00441	CbGpPWpGaD
Nandrolone phenpropionate—AR—Notch-mediated HES/HEY network—CD4—melanoma	0.0042	0.00439	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—FSH signaling pathway—MAPK3—melanoma	0.00416	0.00435	CbGpPWpGaD
Nandrolone phenpropionate—AR—FOXA1 transcription factor network—CDKN1B—melanoma	0.00416	0.00435	CbGpPWpGaD
Nandrolone phenpropionate—AR—Coregulation of Androgen receptor activity—CASP8—melanoma	0.00415	0.00434	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nongenotropic Androgen signaling—MAPK1—melanoma	0.00412	0.00431	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—AURKA—melanoma	0.00408	0.00426	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear SMAD2/3 signaling—CDK2—melanoma	0.00399	0.00417	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—FSH signaling pathway—MAPK1—melanoma	0.00396	0.00414	CbGpPWpGaD
Nandrolone phenpropionate—AR—Notch-mediated HES/HEY network—CDKN1B—melanoma	0.00395	0.00413	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of Androgen receptor activity—MDM2—melanoma	0.00393	0.0041	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—RAC1—melanoma	0.0039	0.00407	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Tryptophan metabolism—MDM2—melanoma	0.00378	0.00395	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear SMAD2/3 signaling—CDK4—melanoma	0.00377	0.00394	CbGpPWpGaD
Nandrolone phenpropionate—AR—Coregulation of Androgen receptor activity—CDKN2A—melanoma	0.00362	0.00378	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—APC—melanoma	0.00359	0.00375	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nongenotropic Androgen signaling—PIK3CA—melanoma	0.00358	0.00374	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—AURKA—melanoma	0.00351	0.00367	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Biological oxidations—CYP17A1—melanoma	0.00335	0.0035	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nongenotropic Androgen signaling—HRAS—melanoma	0.00331	0.00346	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metapathway biotransformation—CYP17A1—melanoma	0.0033	0.00345	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDH1—melanoma	0.0033	0.00345	CbGpPWpGaD
Nandrolone phenpropionate—AR—Notch-mediated HES/HEY network—STAT3—melanoma	0.00325	0.0034	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—melanoma	0.00318	0.00332	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—CLNS1A—melanoma	0.00315	0.00329	CbGpPWpGaD
Nandrolone phenpropionate—AR—Coregulation of Androgen receptor activity—CCND1—melanoma	0.00306	0.00319	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—RB1—melanoma	0.00304	0.00318	CbGpPWpGaD
Nandrolone phenpropionate—AR—Coregulation of Androgen receptor activity—CTNNB1—melanoma	0.00303	0.00316	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nongenotropic Androgen signaling—AKT1—melanoma	0.00292	0.00305	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—melanoma	0.00291	0.00304	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—IL10—melanoma	0.00283	0.00296	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Biological oxidations—CYP1B1—melanoma	0.00282	0.00295	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—E2F1—melanoma	0.00281	0.00294	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—FSH signaling pathway—AKT1—melanoma	0.00281	0.00293	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metapathway biotransformation—CYP1B1—melanoma	0.00278	0.0029	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—SKI—melanoma	0.00276	0.00288	CbGpPWpGaD
Nandrolone phenpropionate—Norethindrone—ALB—melanoma	0.00268	0.0616	CrCbGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—melanoma	0.00264	0.00276	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—MDM2—melanoma	0.00259	0.00271	CbGpPWpGaD
Nandrolone phenpropionate—Norethindrone—ABCB1—melanoma	0.00256	0.0588	CrCbGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—PIP4K2A—melanoma	0.00255	0.00267	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—RAC1—melanoma	0.00255	0.00267	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—CDKN2B—melanoma	0.00254	0.00265	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—ABCB1—melanoma	0.00248	0.00259	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—MMP1—melanoma	0.00247	0.00258	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—melanoma	0.00246	0.00257	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—melanoma	0.00244	0.00255	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—CDK2—melanoma	0.00242	0.00253	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—E2F1—melanoma	0.00242	0.00253	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—melanoma	0.00239	0.0025	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—HIF1A—melanoma	0.00239	0.00249	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—FGF1—melanoma	0.00238	0.00249	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear SMAD2/3 signaling—CDKN1A—melanoma	0.00236	0.00246	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—E2F1—melanoma	0.00233	0.00243	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—PDGFRA—melanoma	0.0023	0.00241	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—ATM—melanoma	0.0023	0.00241	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—CDK4—melanoma	0.00229	0.0024	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—PRKCA—melanoma	0.00228	0.00239	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—CCND1—melanoma	0.00226	0.00236	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—FASLG—melanoma	0.00224	0.00234	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—CTNNB1—melanoma	0.00224	0.00234	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—RAC1—melanoma	0.0022	0.0023	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—PCNA—melanoma	0.0022	0.0023	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—CDKN1A—melanoma	0.00218	0.00228	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—PTEN—melanoma	0.00218	0.00228	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—NPPA—melanoma	0.00216	0.00226	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—FAS—melanoma	0.00216	0.00226	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—CUBN—melanoma	0.00213	0.00223	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—MMP1—melanoma	0.00213	0.00222	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—RAC1—melanoma	0.00212	0.00221	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—CDK2—melanoma	0.00209	0.00218	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—BRAF—melanoma	0.00203	0.00212	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—CDK2—melanoma	0.00201	0.0021	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—CASP8—melanoma	0.00201	0.0021	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—GPAM—melanoma	0.00199	0.00209	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—RB1—melanoma	0.00199	0.00208	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—CDH1—melanoma	0.00198	0.00208	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—ATM—melanoma	0.00198	0.00207	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—melanoma	0.00197	0.00206	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—CDK4—melanoma	0.00197	0.00206	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear SMAD2/3 signaling—MYC—melanoma	0.00195	0.00204	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—STAT3—melanoma	0.00195	0.00204	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—ATM—melanoma	0.00191	0.00199	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—CDK4—melanoma	0.0019	0.00198	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—ACER3—melanoma	0.00188	0.00196	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—APC—melanoma	0.00179	0.00187	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—EGFR—melanoma	0.00177	0.00185	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—EGF—melanoma	0.00177	0.00185	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—BRAF—melanoma	0.00174	0.00182	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—CASP8—melanoma	0.00173	0.00181	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—BCL2—melanoma	0.00172	0.0018	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—UGT2B10—melanoma	0.00172	0.0018	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—RB1—melanoma	0.00171	0.00179	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—CDH1—melanoma	0.00171	0.00179	CbGpPWpGaD
Nandrolone phenpropionate—AR—Coregulation of Androgen receptor activity—AKT1—melanoma	0.0017	0.00178	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—MDM2—melanoma	0.0017	0.00178	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	0.0017	0.00177	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—CASP8—melanoma	0.00166	0.00174	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—IGF1—melanoma	0.00164	0.00171	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—HS3ST5—melanoma	0.0016	0.00167	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—MAP2K1—melanoma	0.00158	0.00165	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—CXCL8—melanoma	0.00155	0.00162	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—CASP3—melanoma	0.00152	0.00159	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—FGF2—melanoma	0.0015	0.00157	CbGpPWpGaD
Nandrolone phenpropionate—Progesterone—ABCB1—melanoma	0.00149	0.0342	CrCbGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—BCL2—melanoma	0.00148	0.00155	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—CASP3—melanoma	0.00148	0.00155	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—CCND1—melanoma	0.00148	0.00155	CbGpPWpGaD
Nandrolone phenpropionate—Testosterone—ALB—melanoma	0.00148	0.0339	CrCbGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—CTNNB1—melanoma	0.00147	0.00153	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—MDM2—melanoma	0.00146	0.00153	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—BCL2—melanoma	0.00143	0.00149	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—PTEN—melanoma	0.00143	0.00149	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—CTNNB1—melanoma	0.00143	0.00149	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—NFKB1—melanoma	0.00142	0.00149	CbGpPWpGaD
Nandrolone phenpropionate—Testosterone—ABCB1—melanoma	0.00141	0.0324	CrCbGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—MDM2—melanoma	0.00141	0.00147	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—ERBB2—melanoma	0.00139	0.00145	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—NFKB1—melanoma	0.00138	0.00145	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—PTGS2—melanoma	0.00136	0.00142	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—melanoma	0.00135	0.00142	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—RPS3—melanoma	0.00135	0.00141	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—SNRPE—melanoma	0.00133	0.00139	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—SKI—melanoma	0.00133	0.00139	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—CASP3—melanoma	0.00131	0.00137	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—VEGFA—melanoma	0.00129	0.00135	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	0.00129	0.00134	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	0.00129	0.00134	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—CCND1—melanoma	0.00127	0.00133	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—melanoma	0.00126	0.00132	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—CDKN2B—melanoma	0.00126	0.00132	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	0.00126	0.00132	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—VEGFA—melanoma	0.00126	0.00131	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—AKT1—melanoma	0.00126	0.00131	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—VDR—melanoma	0.00123	0.00128	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—PTEN—melanoma	0.00123	0.00128	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	0.00123	0.00128	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—NFKB1—melanoma	0.00122	0.00128	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	0.00121	0.00127	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PLCB4—melanoma	0.00121	0.00127	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—FASN—melanoma	0.00119	0.00124	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—MYC—melanoma	0.00119	0.00124	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	0.00119	0.00124	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	0.00118	0.00124	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	0.00118	0.00123	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—MAPK1—melanoma	0.00116	0.00121	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—EGFR—melanoma	0.00116	0.00121	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—SLC6A11—melanoma	0.00114	0.00119	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PIP4K2A—melanoma	0.00114	0.00119	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—melanoma	0.00111	0.00116	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—MTAP—melanoma	0.00111	0.00116	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—KRAS—melanoma	0.0011	0.00115	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	0.00108	0.00113	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—TNF—melanoma	0.00108	0.00113	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	0.00107	0.00112	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—NPPA—melanoma	0.00104	0.00109	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—MYC—melanoma	0.00102	0.00107	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	0.00101	0.00106	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—MAPK1—melanoma	0.000999	0.00104	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—EGFR—melanoma	0.000999	0.00104	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—LUM—melanoma	0.000987	0.00103	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PHGDH—melanoma	0.000987	0.00103	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—MYC—melanoma	0.000983	0.00103	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—TP53—melanoma	0.000975	0.00102	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—HPSE—melanoma	0.000967	0.00101	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	0.000962	0.00101	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	0.000962	0.00101	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CUBN—melanoma	0.00095	0.000993	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—KRAS—melanoma	0.000944	0.000987	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—SDHD—melanoma	0.000917	0.000959	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—BSG—melanoma	0.000917	0.000959	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CSPG4—melanoma	0.000917	0.000959	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—TNF—melanoma	0.000916	0.000958	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	0.000909	0.00095	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—NOTCH1—melanoma	0.000908	0.000949	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GPAM—melanoma	0.000888	0.000929	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—IL6—melanoma	0.000869	0.000909	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—PPARG—melanoma	0.000857	0.000896	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—TP53—melanoma	0.000839	0.000877	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	0.000835	0.000873	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—AKT1—melanoma	0.000823	0.00086	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—TP53—melanoma	0.000808	0.000844	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—HDAC2—melanoma	0.00076	0.000794	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PLA2G6—melanoma	0.000755	0.00079	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—AKT1—melanoma	0.000708	0.00074	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	0.000682	0.000713	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—VCAN—melanoma	0.000678	0.000709	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	0.000642	0.000671	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—melanoma	0.00062	0.000648	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—CDKN2B—melanoma	0.000607	0.000634	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—VDR—melanoma	0.000592	0.000619	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CYP17A1—melanoma	0.000572	0.000598	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	0.000565	0.00059	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—ALB—melanoma	0.000557	0.000583	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—PRKCA—melanoma	0.000546	0.000571	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—ERCC2—melanoma	0.000541	0.000566	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GNA11—melanoma	0.000541	0.000565	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—FASN—melanoma	0.000529	0.000553	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—SLC5A5—melanoma	0.00052	0.000544	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CD44—melanoma	0.000503	0.000525	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GNAQ—melanoma	0.000503	0.000525	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	0.000492	0.000514	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—MYC—melanoma	0.000488	0.000511	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—melanoma	0.000488	0.00051	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CYP1B1—melanoma	0.000482	0.000504	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—NOTCH1—melanoma	0.000437	0.000457	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—melanoma	0.000425	0.000445	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—PPARG—melanoma	0.000413	0.000431	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—ABCB1—melanoma	0.000397	0.000415	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PRKCA—melanoma	0.000365	0.000382	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—ERCC2—melanoma	0.000362	0.000379	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	0.0003	0.000314	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PIK3CG—melanoma	0.000286	0.000299	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PPARG—melanoma	0.000276	0.000289	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PIK3CD—melanoma	0.000251	0.000263	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—ALB—melanoma	0.000248	0.000259	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—MAPK3—melanoma	0.000242	0.000253	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—MYC—melanoma	0.000235	0.000246	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PIK3CB—melanoma	0.000219	0.000229	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PTGS2—melanoma	0.000217	0.000227	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PTEN—melanoma	0.000189	0.000198	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—AKT1—melanoma	0.000163	0.000171	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PIK3CA—melanoma	0.000134	0.00014	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—AKT1—melanoma	0.000109	0.000114	CbGpPWpGaD
